首页> 外文期刊>Journal of Materials Chemistry, B. materials for biology and medicine >Drug delivery systems based on pharmaceutical^ active ionic liquids and biocompatible polydactic acid)
【24h】

Drug delivery systems based on pharmaceutical^ active ionic liquids and biocompatible polydactic acid)

机译:基于药物活性离子液体和生物相容性聚乳酸的药物输送系统

获取原文
获取原文并翻译 | 示例
           

摘要

Poty(L-lactic acid) (PLLA) membranes containing pharmaceutically active ionic liquids (APl-ILs) have been prepared by using a simple film casting from solvent evaporation method. Several sets of membranes were prepared from two different ionic liquids namely 1-methyl-3-butyl-imidazolium ibuprofenate (C4Mlmlbu) and lidocainium ibuprofenate (Lidlbu) with different API—1L contents. Scanning Electron Microscopy (SEM), Differential Scanning Calorimetry (DSC), Wide-Angle and Small-Angle X-ray Scattering (WAXS and SAXS) revealed the strong influence of both the IL nature and content on the morphology and the crystaltinity of the resulting PLLA. At 20 weight%, Lidlbu was shown to act as a plasticizer for PLLA and homogeneous membranes were obtained. In contrast, at the same IL content, phase separation occurred using C4Mlmlbu, resulting in the formation of porous PLLA. An increase of Lidlbu content to 50 weight% results also in phase separation. ~1H and HH-~(13)C CP-MAS NMR measurements evidenced the influence of different morphologies and crystallinities on IL mobility. C4Mlmlbu was found to be highly mobile whereas the mobility of Lidlbu was content dependent. At low percent, low mobility was observed while at higher content, two populations with respectively high and low mobility were observed. These PLLA-IL membranes were further tested as drug delivery systems. In accordance with the morphology and mobility obtained, we demonstrated that release kinetics from PLLA membranes can be tuned by the nature and the content of APl-ILs. Sustainable release kinetics were obtained with API—IL acting as a plasticizer while the fastest release was obtained with API—IL acting as a porogenic agent.
机译:含有药物活性离子液体(AP1-ILs)的Poty(L-乳酸)(PLLA)膜已通过使用简单的溶剂蒸发流延膜方法制备。用两种不同的离子液体制备了几组膜,分别是API-1L含量不同的1-甲基-3-丁基-咪唑鎓布洛芬酸酯(C4Mlmlbu)和布多芬利多卡铵(Lidlbu)。扫描电子显微镜(SEM),差示扫描量热法(DSC),广角和小角X射线散射(WAXS和SAXS)揭示了IL的性质和含量对所得产物的形貌和结晶度的强烈影响PLLA。在20重量%时,Lidlbu被证明充当PLLA的增塑剂,并且获得了均质膜。相反,在相同的IL含量下,使用C4Mlmlbu发生相分离,导致形成多孔PLLA。 Lidlbu含量增加至50重量%也导致相分离。 〜1H和HH-〜(13)C CP-MAS NMR测量证明了不同形态和结晶度对IL迁移率的影响。发现C4Mlmlbu具有高度的移动性,而Lidlbu的移动性取决于内容。在低百分比下,观察到低迁移率,而在高含量下,观察到两个分别具有高和低迁移率的种群。这些PLLA-IL膜已作为药物传输系统进行了进一步测试。根据获得的形态和流动性,我们证明了可以通过AP1-IL的性质和含量来调节从PLLA膜的释放动力学。以API-IL为增塑剂获得了可持续的释放动力学,而以API-IL为致孔剂获得了最快的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号